This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / CosmoFarm_S.A. Record Q2 Revenue
Business earnings report

CosmoFarm_S.A. Record Q2 Revenue

Analysis based on 7 articles · First reported Jun 18, 2026 · Last updated Jun 18, 2026

Sentiment
70
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The positive earnings report from Cosmos Health's subsidiary CosmoFarm is expected to have a positive impact on Cosmos Health's stock price. The investments in automation and expansion signal continued growth and improved profitability, which could attract investor interest in the healthcare sector.

Pharmaceuticals Healthcare Technology
Event Summary

Cosmos Health announced that its subsidiary, CosmoFarm, achieved record revenue of over $15 million in the second quarter of 2026, reaching an annualized run-rate exceeding $60 million. CosmoFarm expanded its distribution network by adding more than 80 new pharmacies in the greater Greece — Athens area. To support this growth, Cosmos Health is increasing capital expenditure at CosmoFarm, investing in robotic automation and artificial intelligence systems for procurement, inventory management, and order fulfillment. The company is also expanding the physical size of the CosmoFarm facility. These strategic investments aim to enhance operational efficiency, improve unit economics, and sustain profitable scaling for CosmoFarm.

Entities Involved
stock
Cosmos Health
Cosmos Health Inc. announced record revenue for its subsidiary CosmoFarm, indicating strong performance and growth in its healthcare group. The company is investing in automation and facility expansion to support this growth.
Importance 100.0 Sentiment 75.0
priv
CosmoFarm
CosmoFarm, a wholly owned subsidiary of Cosmos Health, delivered record revenue of over $15 million in Q2 2026 and expanded its distribution network by adding over 80 new pharmacies. It is a key driver of Cosmos Health's growth.
Importance 95.0 Sentiment 80.0
per
Greg Siokas
As CEO of Cosmos Health, Greg Siokas commented on CosmoFarm's record quarter and the strategic investments being made to sustain its growth and improve profitability.
Importance 60.0 Sentiment 70.0
loc
Greece — Athens
Greece — Athens is mentioned as the primary area where CosmoFarm operates its pharmaceutical wholesale distribution network.
Importance 10.0 Sentiment 0.0
cnt
Greece
Cosmos Health has offices and distribution centers in Thessaloniki and Greece — Athens, Greece.
Importance 10.0 Sentiment 0.0
oth
ROWA
ROWA's robotic systems are part of CosmoFarm's existing automated infrastructure, contributing to operational efficiency.
Importance 5.0 Sentiment 0.0
priv
SSI Schaefer
SSI Schaefer's A-frame robotic systems are utilized by CosmoFarm to enhance operational efficiency and profitability.
Importance 5.0 Sentiment 0.0
priv
ZipDoctor, Inc.
ZipDoctor, Inc. is a telehealth company acquired by Cosmos Health, expanding Cosmos Health's presence in the telehealth space.
Importance 5.0 Sentiment 0.0
govactor
European Union — European Medicines Agency
The European Union — European Medicines Agency certifies Abbott Laboratories's manufacturing practices, ensuring compliance with European Good Manufacturing Practices.
Importance 5.0 Sentiment 0.0
stock
Abbott Laboratories
Abbott Laboratories is a subsidiary of Cosmos Health involved in manufacturing pharmaceuticals and other health products within the European Union.
Importance 5.0 Sentiment 0.0
cnt
United Kingdom
Importance 0.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
alliance
European Union
Importance 0.0 Sentiment 0.0
Relationships
Cosmos Health related ↔ Greg Siokas
Cosmos Health related ↔ Abbott Laboratories
Greg Siokas related ↔ Abbott Laboratories
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.